Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "Japan"

383 News Found

Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


Digital health-start-up MFine raises US $ 48 million
Startup | September 29, 2021

Digital health-start-up MFine raises US $ 48 million

Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions


Fujifilm to verify effectiveness of AI technology in health screening services
Digitisation | September 27, 2021

Fujifilm to verify effectiveness of AI technology in health screening services

This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year


Endimension receives Rs 2.3 crore in seed funding
Startup | September 23, 2021

Endimension receives Rs 2.3 crore in seed funding

The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity


Terumo India releases stamp to commemorate the centenary of Terumo Corporation
Events | September 22, 2021

Terumo India releases stamp to commemorate the centenary of Terumo Corporation

Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide


Imfinzi plus chemotherapy tripled patient survival at 3 years
Biotech | September 20, 2021

Imfinzi plus chemotherapy tripled patient survival at 3 years

The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting


Sharp develops Plasmacluster tech that reduces airborne novel coronavirus
Drug Approval | September 07, 2021

Sharp develops Plasmacluster tech that reduces airborne novel coronavirus

Plasmacluster technology significantly inactivates SARS-CoV-2 contained in adherent saliva in an environment with 60% humidity where the physiological protective function is maintained


Dr Reddy’s enters agreement with Citius to sell rights of its anti-cancer agent
Drug Approval | September 04, 2021

Dr Reddy’s enters agreement with Citius to sell rights of its anti-cancer agent

In March 2016, Dr. Reddy’s had acquired the exclusive global rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai Co.


Sun Pharma Industries announce sale of Kayaku
News | September 02, 2021

Sun Pharma Industries announce sale of Kayaku

The company has been sold to Shinshin Pharmaceuticals